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Abstract
The effects of a PRL-stimulating substance (sulpiride) on PRL and PGF2 secretion and on luteal and ovarian follicular
dynamics were studied during the estrous cycle in mares. A control group (n  9) and a sulpiride group (Sp; n  10) were used.
Sulpiride (25 mg) was given every 8 h from Day 13 postovulation to the next ovulation. Repeated sulpiride treatment did not
appear to maintain PRL concentrations at 12-h intervals beyond Day 14. Therefore, the hypothesis that a long-term increase in
PRL altered luteal and follicular end points was not testable. Hourly samples were collected from the hour of a treatment (Hour
0) to Hour 8 on Day 14. Concentrations of PRL increased to maximum at Hour 4 in the Sp group. The PRL pulses were more
prominent (P  0.008) in the sulpiride group (peak, 19.4  1.9 ng/mL; mean  SEM) than in the controls (11.5  1.8 ng/mL).
Concentrations of a metabolite of PGF2 (PGFM), number, and characteristics of PGFM pulses, and concentrations of
progesterone during Hours 0 to 8 were not affected by the increased PRL. A novel observation was that the peak of a PRL pulse
occurred at the same hour or 1 h later than the peak of a PGFM pulse in 8 of 8 PGFM pulses in the controls and in 6 of 10 pulses
in the Sp group (P 0.04), indicating that sulpiride interfered with the synchrony between PGFM and PRL pulses. The hypothesis
that sulpiride treatment during the equine estrous cycle increases concentrations of PRL and the prominence of PRL pulses was
supported.
© 2012 Elsevier Inc. All rights reserved.
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1. Introduction
The luteolytic process consists of both functional
and structural regression of the CL. Assay of plasma
concentrations of progesterone (P4) and transrectal ul-
trasonic evaluation of the CL and percentage of CL
with color-Doppler blood flow signals can be used to
evaluate the CL in large animals [1,2]. In mares, the
average day of transition from preluteolysis to luteoly-
sis is Day 14 (Day 0  ovulation), based on collection
of hourly blood samples [3]. Secretion of PGF2 pulses
by the endometrium has a fundamental role in luteoly-
sis in mares [2,3] as in other species [4,5].
Prolactin (PRL) has luteotropic and luteolytic roles in
some species [6]. In cows, a luteal role for PRL has not
been demonstrated, despite the presence of PRL receptors
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and the expression of PRL mRNA in the CL [7]. In mares,
specific PRL binding sites are uniformly distributed in the
mature CL [8], but a luteal role of PRL has not been
demonstrated in vitro or in vivo. Concentrations of PRL
are greater during the ovulatory season (summer) than
during the anovulatory season (winter [8–12]). Collection
of blood samples every 4 h [13] is too infrequent to detect
PRL pulses during the estrous cycle in mares, but infre-
quent collections (4- to 24-h intervals) have depicted one
to three apparent transient increases toward the end of
luteolysis and during estrus [8,10,13]. On the basis of
hourly blood sampling, PRL pulse peaks are greater dur-
ing and after luteolysis than during preluteolysis in mares
[14] and heifers [15]. Synchrony of peaks between pulses
of PRL and a metabolite of PGF2 (PGFM) is most
frequent during late luteolysis and after luteolysis [14,15].
However, whether pulses of PGF2 stimulate a pulse of
PRL or vice versa, and whether other factors are involved
in the PGFM/PRL synchrony, have not been demon-
strated.
Prolactin secretion is regulated by the hypothalamus
via a short-loop feedback system [16]. The major pro-
lactin inhibiting factor is dopamine, which has been
reported to decrease PRL secretion both in vitro [17]
and in vivo [18]. Sulpiride, a dopamine receptor antag-
onist, stimulates PRL secretion. In mares, most studies
using sulpiride treatments have involved lactation
[19,20] and the anovulatory and ovulatory seasons
[9,21,22]. Increasing PRL concentrations by dopamine
antagonists stimulates ovarian follicular development
and hastens the first ovulation of the ovulatory season
[21,22]. Although considerable attention has been
given to the role of PRL in reproductive seasonality,
only limited information is available regarding the ef-
fects of stimulation during the estrous cycle. Sulpiride
increases PRL concentrations in mares that are in estrus
or diestrus [9], but the effects of sulpiride on PRL
concentrations during specific days relative to luteal
stages or follicular development, or the effects of in-
creased PRL on the CL or follicles during the ovulatory
season, have not been reported. In addition, the effects
of sulpiride on the number and characteristics of indi-
vidual PRL pulses apparently have not been reported
for any reproductive status or species.
The presence of PRL receptors in the pituitary [23]
indicates a potential role of PRL on pituitary function.
Secretion of PRL has been reported to inhibit LH se-
cretion in several species [24], especially in rats and
humans [25,26]. The combined effect of PRL and do-
pamine inhibits LH, but PRL alone does not. Sulpiride
treatment did not alter LH concentrations in mares
during the anovulatory season or during diestrus [9],
but the effect of a PRL increase on circulating concen-
trations of LH and FSH in mares requires further study,
especially during the estrous cycle.
The present experiment was done from Day 13 to
ovulation in mares to evaluate the following hypothe-
ses: (1) sulpiride treatment during the estrous cycle
increases PRL concentrations and the prominence of
PRL pulses; (2) an increase in PRL concentration af-
fects PGFM concentration and pulses and P4 concen-
tration; and (3) repeated sulpiride treatment (every 8 h)
maintains an increase in PRL and alters structural luteal
regression, luteal blood flow, follicle development, and
time of ovulation. In addition, the effects of sulpiride
treatment on temporal relationships between PRL and
PGFM pulses were determined.
2. Materials and methods
2.1. Animals and ultrasound scanning
Mixed breeds of large pony mares and apparent
pony-horse crosses (n 20) averaging 430 kg and aged
4 to 13 y were used during August in the northern
temperate zone. The mares were housed under natural
light in an open shelter, with free access to a mixture of
alfalfa and grass hay, water, and trace-mineralized salt.
Mares were selected on Day 13 (ovulation  Day 0);
they had no apparent abnormalities of the reproductive
tract or undersized CL (3 cm2), as determined by
transrectal ultrasound examinations [27]. Mares were
handled according to the United States Department of
Agriculture Guide for Care and Use of Agricultural
Animals in Agricultural Research.
A duplex B-mode (gray-scale) and pulsed-wave color-
Doppler ultrasound scanner (Aloka SSD-3500; Aloka
America, Wallingford, CT, USA) equipped with a 7.5
MHz transrectal linear-array transducer was used for ul-
trasound examinations. Number of follicles 15 mm and
diameter of the largest follicle were determined twice
daily, beginning on Day 13. The area of the CL was
measured twice daily at the maximal image plane, using
the scanner’s still image and tracing function. Blood flow
in vessels of the CL was displayed in power-Doppler
mode while scanning the entire CL in real time. The
percentage of the CL that displayed color signals of blood
flow was estimated as described and validated [28,29].
2.2. Experimental design and treatments
Mares were randomized into a control and sulpiride
(Sp) group (n 10 per group). Sulpiride in a sesame oil
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vehicle (Rood and Riddle Pharmacy, Lexington, KY,
USA) was given intramuscularly. The controls did not
receive a vehicle. From Day 13 to ovulation, mares in
the Sp group were given 25 mg of sulpiride thrice daily
at 8 AM, 4 PM, and 12 AM (every 8 h). The dose of
sulpiride and interval between treatments were based
on a previous report [30]; the PRL increase from a 25
mg dose was similar to a 100 mg dose, and both doses
induced elevated PRL concentrations for at least 7 h.
Beginning on Day 13, blood samples were collected by
venipuncture of a jugular vein at 1 AM and 1 PM (every
12 h) until ovulation (Fig. 1). The 12-h samples were
used for long-term evaluation of progesterone (P4) con-
centrations, CL area (cm2), luteal blood flow, number
of follicles 15 mm, and growth of the largest follicle.
In addition, samples were collected hourly for 12 h on
Day 14 (beginning at 2 PM). Beginning sampling at 2 PM
was based on a report that eight of eight mares began
luteolysis between 2 PM and 2 AM [31]. Hourly sampling
extended from 3 h before to 8 h after the fifth sulpiride
treatment at 8-h intervals. The hour of treatment was
designated Hour 0. Hours 0 to 8 were used for study of
concentrations of P4 and concentrations and pulses of
PRL, PGFM, LH, and FSH. The hourly sampling was
done on Day 14 to correspond to the mean day of the
beginning of luteolysis, as previously reported [3]. The
length of luteolysis is 23 h on the basis of hourly blood
sampling.
The P4 concentrations at Hours3 to1 were used
to determine luteal stage (preluteolysis, luteolysis, post-
luteolysis) at Hour 0. The luteal transition from prelu-
teolysis to luteolysis was based on a progressive de-
crease in P4 at the peaks of P4 fluctuations, as
described [31]. The period before luteal transition was
defined as preluteolysis. The hour of transition was
compared between the control and Sp groups. The
period beginning at the luteal transition and extending
until P4 1 ng/mL was defined as luteolysis; all sam-
ples with P4 1 ng/mL indicated postluteolysis [3].
Fluctuations of PRL, PGFM, LH, and FSH concen-
trations were evaluated to detect pulses during Hours 0
to 8, as described [1]. When the coefficient of variation
(CV) of the values comprising a fluctuation from be-
ginning to ending nadirs was at least three times greater
than the mean intra-assay CV, the fluctuation was con-
sidered to be a pulse. The adequacy for detecting pulses
of PRL and PGFM [14] and LH [32] by hourly sam-
pling in mares for this approximate stage of the estrous
cycle has been reported. The interval from Hour 0 to
the peak of a PRL pulse was compared between groups.
The synchrony (at same hour) for the peaks of PRL and
PGFM pulses was examined for differences between
groups. Concentrations of P4 were centralized to the
peak of a PRL pulse to determine if the pulses influ-
enced the direction of P4 change within the hours of a
PRL pulse.
Discrete end points for both PRL and PGFM pulses
were number of pulses per 8 h; concentration at the
beginning nadir (Nadir 1), peak, ending nadir (Nadir 2),
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Fig. 1. Mean  SEM concentrations of progesterone (P4), area (cm2)
of CL, and percentage of CL with power-Doppler signals of blood
flow in controls and sulpiride-treated mares. Sulpiride treatment was
given every 8 h from Day 13 to ovulation. For each end point, only
the day effect (D) was significant.
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and amplitude (concentrations at peak minus Nadir 1);
area under the curve; and interval (elapsed number of
hours) from Nadir 1 to Nadir 2.
2.3. Hormone assays
Blood samples were collected into heparinized tubes
(10 mL) and immediately placed in ice water for 10 min
before centrifuging (2000  g for 10 min). The plasma
was decanted and stored (20°C) until assayed. Plasma
concentrations of PRL were determined by an RIA that
was validated and described for use in equine plasma in
our laboratory [33]. The intra-assay CV and sensitivity
were 5.8% and 0.03 ng/mL, respectively. Concentrations
of PGFM were assayed by ELISA, as developed in our
laboratory for bovine plasma [34] and adapted and vali-
dated for use in equine plasma [3]. The intra- and inter-
assay CV and sensitivity were 5.1%, 19.9%, and 9.5
pg/mL, respectively. Plasma P4 was measured by a solid-
phase RIA kit containing antibody-coated tubes and I125-
labeled progesterone (Coat-A-Count Progesterone; Diag-
nostic Products Corporation, Los Angeles, CA, USA),
validated and described for equine plasma in our labora-
tory [35]. The intra-assay CV and sensitivity were 3.9%
and 0.03 ng/mL, respectively. Concentrations of LH and
FSH were analyzed by RIA, as described for mare plasma
in our laboratory [36]. The intra-assay CV and sensitivity
were 9.9% and 0.23 ng/mL for LH, and 14.2% and 1.1
ng/mL for FSH, respectively.
2.4. Statistical analyses
Data were examined for normality using the Shapiro–
Wilk test. Data that were not normally distributed were
transformed to natural logarithms or ranks. The Dixon test
was used for detection and removal of outliers from the
statistical analyses. Outliers were detected for two PRL
values. Factorial analyses for main effects of group and
hour and the group-by-hour interaction were done with
SAS PROC MIXED (Version 9.2; SAS Institute, Inc.,
Cary, NC, USA) with a REPEATED statement to mini-
mize autocorrelation between sequential measurements.
When the interaction between group and hour was signif-
icant or approached significance, differences between
groups at each hour were examined by Student unpaired
t-tests. The LSD test was used to locate differences among
hours within groups or hours. Student paired t-tests were
used for selected comparisons of means within a group.
Differences between groups for discrete characteristics
were analyzed by Student unpaired t-tests. Chi-square was
used to test independence in the frequency of pulses
among groups, and chi-square goodness-of-fit was used to
test equality (e.g., number of luteal stages within a group).
For all analyses, P  0.05 indicated a difference was
significant, whereas P  0.05 to P  0.1 indicated that
significance was approached. Data are presented as the
mean  SEM, unless otherwise noted.
3. Results
Probabilities for a group effect, hour effect, and
group-by-hour interaction for the factorial analyses are
given in the figures and the probabilities for differences
in discrete end points are given in the tables or text.
One mare in the controls had a persistent CL (until Day
70) and was excluded from the analyses, leaving nine
mares in the controls and 10 mares in the Sp group. On
the basis of P4 concentrations, the number of mares in
the three luteal stages at the hour of treatment (Hour 0)
on Day 14 was not different between groups (for con-
trol and Sp groups, respectively: preluteolysis, 3 and 6;
luteolysis, 5 and 3; postluteolysis, 1 and 1). Eight of
nine mares that were in preluteolysis at Hour 0 were in
luteal transition between preluteolysis and luteolysis at
Hours 0, 1, or 2. Four mares began postluteolysis dur-
ing Hours 2 to 6.
Concentrations of P4 were significant for day, but
not for group effect or for the group-by-day interaction
for samples taken every 12 h on Days 13.0 to 15.5 (Fig.
1). The day effect was from a progressive concentration
decrease averaged for the two groups. The number of
days from ovulation to the first P4 sample with a con-
centration 1.0 ng/mL (end of luteolysis) was not
different between the controls (14.8 0.2 days) and the
Sp group (15.1  0.2 days). The end of luteolysis to
ovulation was not different between the controls (7.1
0.5 days) and the Sp group (6.7 0.4 days). Both luteal
area (cm2) and percentage of CL with power-Doppler
blood flow signals had a day effect for Days 13.0 to
18.5, but not a group effect or interaction (Fig. 1).
Concentrations of PRL for Days 13.0 to 21.5 (Fig. 2)
or for the 6 days before the posttreatment ovulation (not
shown) were not different in the factorial analyses
(group, day, or interaction). Based on unpaired t-tests,
the only PRL difference between groups within a day
occurred on Day 13.0; PRL was greater (P  0.04) in
the Sp group than in the controls. When analyzed sep-
arately, a day effect (P  0.0001) was detected only in
the Sp group. The only significant continuing change
between days within a group was a decrease (P 
0.003) between Days 13.0 and 16.0 in the Sp group.
Diameter of the largest follicle for Days 13 to 21.5
increased over days (Fig. 2). The number of follicles
15 mm from Days 13.0 to 21.5 also had only a day
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effect. The day effect represented an increase (P 
0.002) in number averaged over the two groups be-
tween Days 13.0 and 16.5, followed by a decrease until
Day 21.5 (P  0.006). The interovulatory interval was
not different between the controls (22.1  0.6 days)
and the Sp group (22.0  0.5 days). There were no
hemorrhagic anovulatory follicles [37] in either group.
Hourly concentration of P4 between Hours 3 and
8 on Day 14 had only an hour effect from decreasing
concentrations in each group (Fig. 3). The hourly P4
concentrations did not change during Hours 3 to 0 in
either group. The hourly concentrations of PRL during
Hours3 to 8 on Day 14.0 had significant main effects
of group and hour, but no interaction (Fig. 3). The
group effect was from greater overall concentration in
the Sp group (10.1  0.5 ng/mL) than the controls
(5.0  0.7 ng/mL). Although the interaction was not
significant, PRL concentration was greater (P  0.05)
in the Sp group than in the controls at Hours 3 and
Hours 0 to 5. When each group was considered separately,
there was an hour effect only for the Sp group (P 
0.0001). Hourly PRL concentrations decreased (P 
0.0001) between Hours 3 and 0 in the Sp group. An
increase (P  0.003) occurred between Hours 0 and 1,
reached maximum at Hour 4, and then decreased, so that
the concentration at Hour 8 was not significantly different
from the concentration at Hour 0; the difference between
Hours 0 and 7 approached significance (P 0.06). There
was no hour or group effect or interaction for concentra-
tions of PGFM (Fig. 3). Concentrations of LH or FSH
during Hours 0 to 8 did not differ for the main effects or
for the interaction (not shown).
Prolactin pulses during Hours 0 to 8 had a greater
overall concentration (group effect) in the Sp group
(11.8  0.8 ng/mL) than in the controls (5.1  0.7
ng/mL; Fig. 4). There was no group-by-hour interac-
tion. Discrete characteristics of PRL and PGFM pulses
during Hours 0 to 8 are shown (Table 1). Concentra-
tions of PRL were significantly greater in the Sp group
than in the controls for the peak, Nadir 2, and ampli-
tude; concentration at Nadir 1 approached being greater
and area under the curve was greater in the Sp group.
The number of pulses per 8 h and the interval from
Nadir 1 to Nadir 2 were not different between groups
(Table 1). The interval from Hour 0 to the peak of a
PRL pulse was shorter (P  0.05) for the Sp group
(3.0  0.4 h) than for the controls (4.3  0.6 h). More
PRL pulse peaks tended to occur during Hours 2 to 4
(eight pulses) than during Hours 5 to 7 (one pulse) in
the Sp group (P  0.08). The eight versus one pulse in
the Sp group differed (P  0.02) from equality. The
number was similar between Hours 2 to 4 (five pulses)
and Hours 5 to 7 (five pulses) in the controls.
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The number and characteristics of PGFM pulses did
not differ between groups (Fig. 4, Table 1). The number
of PGFM pulses per 8 h (1.6  0.2) was greater (P 
0.002) than the number of PRL pulses (1.0  0.2) for
the Sp group. The number of PGFM pulses did not
differ from the number of PRL pulses in the controls.
The interval from a PGFM peak to the closest PRL
peak was longer (approached significance, P 0.08) in
the Sp group (1.0  0.3 h) than in the controls (0.4 
0.2 h). The peak of a PRL pulse occurred at the same
hour or 1 h later than the peak of a PGFM pulse in eight
of eight PGFM pulses in the controls and 6 of 10 pulses
in the Sp group (P 0.04). Pulses of LH and FSH were
not detected during Hours 0 to 8 by the CV method.
4. Discussion
The luteal transition between preluteolysis and lute-
olysis in mares is manifested within 1 h, based on
hourly determination of P4 concentration and occurred
between 2 PM and 2 AM in eight of eight mares [31]. In
the current study, eight of nine mares that were in
preluteolysis at the beginning of hourly sampling at 2
PM began the transition between preluteolysis and lute-
olysis at 5, 6, or 7 PM. The remaining mare remained in
preluteolysis throughout the 12 h. There were no dif-
ferences among the three groups in the number of
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mares that were either in luteolysis throughout the 12 h
of hourly sampling (n  total of 4) or began (n  8) or
ended luteolysis during the 12 h (n  4). Thus, the
group effects on PGFM and PRL cannot be attributed to
the chance occurrence of mares in different luteal
stages among groups.
4.1. Hypothesis 1
Sulpiride treatment during the estrous cycle in-
creases PRL concentration and the prominence of PRL
pulses was supported. The support for PRL secretion
was shown in the hourly samples collected on Day 14
from Hour 0 (treatment hour) to Hour 8 by the follow-
ing: (1) PRL concentrations averaged over hours were
greater in the Sp group; and (2) PRL concentrations in
the Sp group began to increase immediately to a max-
imum at Hour 4 and then decreased, so that Hour 6 was
the last hour with concentration greater than the con-
centration at treatment. The duration of the sulpiride
effect seemed similar to what was previously reported
for the 25 mg dose during the estrous cycle [30]. In the
previous experiment, sulpiride was given as a single
bolus treatment, and the PRL concentrations were max-
imum at the first blood sample 15 min after treatment
and then gradually decreased. In contrast, in the current
study, the Sp group received four treatments at 8-h
intervals before the treatment at Hour 0. Thus, it ap-
peared that a single sulpiride treatment induced an
immediate PRL increase, whereas treatment after pre-
vious exposure to sulpiride induced a gradual increase
over several hours. The comparison between the two
reports suggests that a single treatment caused an im-
mediate release of PRL from pituitary stores, whereas
sequential treatments required additional time for syn-
thesis of PRL. In the current study, PRL concentrations
were greater in the Sp group than in the controls at
Hour 0 and even greater at Hour 3; these elevated
concentrations were attributed to the residual concen-
trations from previous treatments at 8-h intervals. Al-
though there were no significant differences in the
factorial analysis of PRL concentration at 12-h intervals
in the two groups, a decrease was detected (paired
t-tests) between Days 13.0 and 16.0 in the Sp group.
That the concentration was greater on Day 13.0 in the
Sp group than in the controls was attributed to sulpiride
treatment 5 h before the Day 13.0 blood sample.
The increase in the prominence of PRL pulses by
sulpiride treatment was a novel finding, in that previous
sulpiride studies did not consider PRL pulsatility. The
pulsatility of PRL in nontreated animals was demon-
strated only recently in mares [14] and heifers [15]. The
greater prominence of PRL pulses in the Sp group was
indicated by the greater means of all values in a pulse;
by the greater concentrations at the peak, Nadir 2, and
amplitude; and by the greater area under the curve of a
PRL pulse. The number of PRL pulses per 8 h did not
differ between the control and Sp groups, but the dis-
tribution of pulses was different. In the controls, pulses
were distributed evenly between Hours 2 to 4 and
Hours 5 to 7. However, in the Sp group, all pulses but
one occurred during Hours 2 to 4. The decrease in
number of pulses during Hours 5 to 7 likely reflected
the length of the 5-h interpulse interval in heifers [15].
4.2. Hypothesis 2
An increase in PRL concentration affects PGFM
concentration and pulses and P4 concentration was
not supported. The hourly concentrations (Hours 0 to
Table 1
Mean  SEM characteristics of PRL and PGFM pulses during 8 h of hourly sampling after treatment in a control group (n  9 mares) and a
sulpiride group (n  10 mares).
PRL PGFM
Pulse end points Control Sulpiride P Control Sulpiride P
Number of pulses per 8 h 1.0  0.2 1.0  0.2 NS 1.2  0.1 1.6  0.2 NS
Concentrations (PRL, ng/mL; PGFM, pg/mL)
Nadir 1a 3.3  1.2 4.9  0.7  0.06 16.3  2.1 21.7  3.4 NS
Peak 11.5 1.8 19.4  1.9  0.008 252.1 63.0 200.4  73.0 NS
Nadir 2a 2.4  1.4 6.8  1.9  0.04 40.0  18.1 27.3  10.5 NS
Amplitudeb 8.2  2.1 13.9  2.2  0.009 240.1 69.4 178.7  71.3 NS
AUC (ng/mL per h) 17.4  3.5 44.0  6.2  0.003 448.2 160.6 363.9  156.2 NS
Pulse base (h)c 5.2  1.1 6.0  0.6 NS 5.4  1.0 5.1  0.6 NS
AUC, area under curve; NS, not significant.
a Nadir 1 is at the beginning of a pulse and Nadir 2 is at the end of a pulse.
b Concentration at peak minus at Nadir 1.
c Interval between Nadirs 1 and 2.
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8) of PGFM and the number and characteristics of
PGFM pulses were not significantly different be-
tween groups, despite the increased concentration
and prominence of PRL pulses. Based on the absence
of PGFM stimulation during the PRL increase, we
inferred that the synchrony between PGFM and PRL
pulses [14] represented a positive effect of PGF2 on
PRL, rather than an effect of PRL on PGF2. A
novel observation was the greater synchrony of
PGFM and PRL pulses in the controls than in the Sp
group. This was indicated by the occurrence of a
PRL pulse peak on the hour of or after a PGFM pulse
peak in all PGFM pulses in the controls, compared
with 60% of pulses in the Sp group. That is, the
greater prominence of PRL pulses in the Sp group
partially interfered with the PGFM/PRL synchrony.
Progesterone concentration did not differ between
groups during the hourly sampling on Day 14 (factorial
analyses detected only a day effect, but no group effect
or interaction). Furthermore, unpaired t-tests did not
detect a significant difference between groups for any
day or hour. In addition, the day of the end of luteolysis
(P4, 1 ng/mL) was not different between groups. In
addition, P4 concentrations did not increase during a
pulse of PRL. This result also failed to detect a luteo-
tropic effect of a PRL pulse on P4 in mares, unlike the
positive intrapulse effect of an LH pulse on P4 in
heifers [32]. Despite the presence of PRL receptors in
the CL of mares [8], the current in vivo study did not
demonstrate either a positive or a negative effect of
PRL on the CL or P4 production.
4.3. Hypothesis 3
Repeated sulpiride treatment (every 8 h) maintains
an increase in PRL and alters structural luteal regres-
sion, luteal blood flow, follicle development, and time
of ovulation was not supported. The luteal end points
decreased after Day 13 as expected during luteolysis,
but with no effect of group or group-by-hour interac-
tion. The diameter of the largest follicle, length of the
interval from the end of luteolysis to ovulation, and
length of the interovulatory interval were not altered by
sulpiride. The gradual increase in diameter of the larg-
est follicle until Day 21.5 and the increase in number of
follicles 15 mm between Days 13.0 and 16.5, fol-
lowed by a decrease in number averaged over the two
groups, were consistent with the emergence and char-
acteristics of the ovulatory follicular wave [38]. That is,
there was no indication that sulpiride treatment altered
development of the ovulatory follicular wave. How-
ever, the CL and follicle portion of the hypothesis was
not adequately tested, because of the apparent absence
of a sustained PRL response to repeated sulpiride treat-
ment. Future studies may require a larger dose of
sulpiride [39]. On the first day (Day 13) in the current
study, the sulpiride treatment greatly increased PRL
secretion, but the PRL concentrations gradually dimin-
ished at 12-h intervals, despite each successive treat-
ment. In this regard, a PRL increase might have been
detected if hourly posttreatment blood samples were
taken after Day 14. This hypothesis, therefore, requires
further consideration in a future study during the es-
trous cycle. The reduced response to repeated sulpiride
treatments was also observed in an experiment during
the anovulatory season [40]; mares were treated daily
and PRL decreased markedly from the first to the sixth
day of treatment. During the transition from anovula-
tory to ovulatory seasons, sulpiride treatments (once or
twice a day) maintained elevated PRL for 25 to 58 days
[21,22,40]. However, the doses used were 8 to 20 times
greater than the current dose.
These gonadotropins were not detected during
Hours 0 to 8 in either group. In previous studies during
the anovulatory season, sulpiride treatment did not alter
concentrations of LH [9] or concentrations of either LH
or FSH [40]. These studies have indicated that increas-
ing the concentrations of PRL in mares does not affect
the circulatory concentrations of gonadotropins on ei-
ther Day 14 of the estrous cycle or during the anovu-
latory season.
4.4. Conclusion
In conclusion, treatment of mares with 25 mg of
sulpiride on Day 14 increased the hourly PRL concen-
trations from the hour of treatment (Hour 0) to Hour 4.
Concentrations then decreased and by Hour 7 were no
longer greater than the concentration at Hour 0. During
Hours 0 to 8, concentrations of PGFM, P4, LH, and
FSH were not altered by the increased PRL concentra-
tions. Pulses of PRL occurred earlier in the sulpiride-
treated group, and the synchrony between pulses of
PGFM and PRL was partially disrupted. The increased
PRL did not affect PGFM concentrations or pulses,
indicating that the synchrony between PGFM and PRL
pulses was not from an effect of PRL on PGFM. Re-
peated sulpiride treatment every 8 h from Day 13 to
ovulation resulted in a diminishing PRL response.
Blood sampling at 12-h intervals did not detect a PRL
increase after Day 13 and the CL area (cm2), luteal
blood flow, ovarian follicular development, and the
interovulatory interval, were not altered.
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